Abstract
Background The promises of improved health care and health research through data-intensive applications rely on a growing amount of health data. At the core of large-scale data integration efforts, clinical data warehouses (CDW) are also responsible of data governance, managing data access and (re)use. As the complexity of the data flow increases, greater transparency and standardization of criteria and procedures is required in order to maintain objective oversight and control. This study assessed the spectrum of data access and use criteria and procedures in clinical data warehouses governance internationally.
Methods We performed a systematic review of (a) the published scientific literature on CDW and (b) publicly available information on CDW data access, e.g., data access policies. A qualitative thematic analysis was applied to all included literature and policies.
Results Twenty-three scientific publications and one policy document were included in the final analysis. The qualitative analysis led to a final set of three main thematic categories: (1) requirements, including recipient requirements, reuse requirements, and formal requirements; (2) structures and processes, including review bodies and review values; and (3) access, including access limitations.
Conclusions The description of data access and use governance in the scientific literature is characterized by a high level of heterogeneity and ambiguity. In practice, this might limit the effective data sharing needed to fulfil the high expectations of data-intensive approaches in medical research and health care. The lack of publicly available information on access policies conflicts with ethical requirements linked to principles of transparency and accountability.
CDW should publicly disclose by whom and under which conditions data can be accessed, and provide designated governance structures and policies to increase transparency on data access. The results of this review may contribute to the development of practice-oriented minimal standards for the governance of data access, which could also result in a stronger harmonization, efficiency, and effectiveness of CDW.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: all authors had financial support from HiGHmed, Medical Informatics Consortium, for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
This study was funded by the German Federal Ministry of Education and Research (BMBF; HiGHmed, Medical Informatics Consortium, Medizinische Hochschule Hannover, 01ZZ1802C).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
An extensive part of the data analyzed during this study is included in this published article and its supplementary files (Supplement Table 3). The raw dataset analyzed during the current study is not publicly available in full due to copyright restrictions but is available from the corresponding author on reasonable request.
LIST OF ABREVIATIONS
- BMBF
- German Federal Ministry of Education and Research
- CDW
- Clinical data warehouse
- EHR
- Electronic health records
- LHCS
- Learning health care systems
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- WMA
- World Medical Association
